» Articles » PMID: 23634721

Quantifying the Use of Bioresources for Promoting Their Sharing in Scientific Research

Abstract

An increasing portion of biomedical research relies on the use of biobanks and databases. Sharing of such resources is essential for optimizing knowledge production. A major obstacle for sharing bioresources is the lack of recognition for the efforts involved in establishing, maintaining and sharing them, due to, in particular, the absence of adequate tools. Increasing demands on biobanks and databases to improve access should be complemented with efforts of end-users to recognize and acknowledge these resources. An appropriate set of tools must be developed and implemented to measure this impact.To address this issue we propose to measure the use in research of such bioresources as a value of their impact, leading to create an indicator: Bioresource Research Impact Factor (BRIF). Key elements to be assessed are: defining obstacles to sharing samples and data, choosing adequate identifier for bioresources, identifying and weighing parameters to be considered in the metrics, analyzing the role of journal guidelines and policies for resource citing and referencing, assessing policies for resource access and sharing and their influence on bioresource use. This work allows us to propose a framework and foundations for the operational development of BRIF that still requires input from stakeholders within the biomedical community.

Citing Articles

Gaps between Open Science activities and actual recognition systems: Insights from an international survey.

Grattarola F, Shmagun H, Erdmann C, Cambon-Thomsen A, Thomsen M, Kim J PLoS One. 2024; 19(12):e0315632.

PMID: 39680530 PMC: 11649118. DOI: 10.1371/journal.pone.0315632.


Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine.

Sanchez-Lopez A, Catalina P, Franco F, Panadero-Fajardo S, Rejon J, Romero-Sanchez M J Pers Med. 2024; 14(7).

PMID: 39063922 PMC: 11277733. DOI: 10.3390/jpm14070668.


Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study.

Motta B, Grander C, Gogele M, Foco L, Vukovic V, Melotti R J Transl Med. 2019; 17(1):408.

PMID: 31801616 PMC: 6891972. DOI: 10.1186/s12967-019-02130-z.


Ensuring Effective Utilization of Biospecimens: Design, Marketing, and Other Important Approaches.

Bledsoe M, Sexton K Biopreserv Biobank. 2019; 17(3):248-257.

PMID: 31188625 PMC: 6588104. DOI: 10.1089/bio.2019.0007.


Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.

Langhof H, Kahrass H, Illig T, Jahns R, Strech D Eur J Hum Genet. 2018; 26(11):1572-1581.

PMID: 30089824 PMC: 6189200. DOI: 10.1038/s41431-018-0228-x.


References
1.
Kaye J . Building a foundation for biobanking: the 2009 OECD guidelines on human biobanks and genetic research databases (HBGRDs). Eur J Health Law. 2010; 17(2):187-90. DOI: 10.1163/157180910x12665776638821. View

2.
Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielski E . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2000; 29(1):308-11. PMC: 29783. DOI: 10.1093/nar/29.1.308. View

3.
Joly Y, Zeps N, Knoppers B . Genomic databases access agreements: legal validity and possible sanctions. Hum Genet. 2011; 130(3):441-9. DOI: 10.1007/s00439-011-1044-3. View

4.
Garfield E . The history and meaning of the journal impact factor. JAMA. 2006; 295(1):90-3. DOI: 10.1001/jama.295.1.90. View

5.
Peterson J, Campbell J . Marker papers and data citation. Nat Genet. 2010; 42(11):919. DOI: 10.1038/ng1110-919. View